Needle-Free Injection Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Zogenix, Inovio, Glide Pharma, Akra Dermojet

The Needle-Free Injection Market size was valued at US$ 130 million in 2021, and expected to increase to US$ 290 billion by 2027, at a CAGR of 17.5% from 2022 to 2027.

Needle-Free Injection Market Overview

Growth in this market is primarily driven by technical developments, rising demand for self-injection devices, and the rising prevalence of chronic conditions. Globally, the number of patients has greatly increased due to the growing geriatric population and the rising frequency of chronic diseases. As a result, there is an increased need for cutting-edge and efficient treatment methods, such as the usage of needle-free injection techniques. Furthermore, this industry is expanding due to the widespread use of improved drug delivery methods. On the other hand, intravenous administration systems and huge volume restrictions are the main obstacles impeding the market's expansion. The frequency of infectious diseases worldwide is remains high, despite great advancements in sanitation and medicine. Infectious diseases continue to be a major public health problem worldwide, despite the fact that non-communicable diseases are the principal causes of morbidity and mortality. Over 15 million people die each year from infectious diseases worldwide, according to the National Institute of Allergy and Infectious Diseases (NIAID). In 2019, there were 229 million cases of malaria worldwide, according to the World Malaria Report of the World Health Organization (WHO).

The majority of healthcare professionals are extremely concerned about needlestick wounds caused by infected needles. One of the most serious risks to health and safety is injury from needles. Medical professionals are at a high risk of exposure to blood-borne pathogens due to accidental needlestick injuries because injections are one of the most widely utilized methods for drug administration. Approximately 385,000 healthcare professionals stab themselves unintentionally each year, according to the CDC. Healthcare workers who sustain injuries from needlesticks run the risk of contracting infectious diseases like hepatitis B, hepatitis C, and AIDS.

Industry News and Updates:

December 14, 2021: PharmaJet partner, Nykode Therapeutics announces phase 1/2 clinical trial with next generation DNA-based COVID-19 vaccine candidates --

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that one of its pharmaceutical partners, Nykode Therapeutics (formerly Vaccibody) has begun a phase 1/2 clinical trial to specifically address emerging SARS-CoV-2 variants. The DNA-based vaccines will be delivered intramuscularly in the clinical trial exclusively using the PharmaJet Stratis® Needle-free Injection System. Nykode Therapeutics is a clinical-stage biopharmaceutical company dedicated to the discovery and development of DNA-based vaccines and novel immunotherapies for the treatment of cancer and infectious diseases. 

What are the major Applications, Types and Regions for Needle-Free Injection Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Powder Injections


• Liquid Injections


• Depot or Projectile Injection

By Application, it is segmented into

• Drug Injection


• Cosmetic Surgery Use


• Other

Needle-Free Injection Market Regional Analysis

North America accounted for 58% of the needle-free injection market in 2020, followed by Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa. However, throughout the projected period, the APAC region is anticipated to develop at the highest CAGR of 18.7%. Growing investments by major market players in the region, an ageing population, rising life expectancy, rising per capita income, the expansion of private hospitals & clinics to rural areas, the availability of low-cost labour for manufacturing, the presence of a favourable regulatory environment, and rising demand for self-injectable devices testing are all factors that are assisting market growth in the APAC region. The needle-free injection systems market in APAC is anticipated to grow most quickly during the next ten years. This may be a result of rising income levels and rising healthcare costs in emerging economies. Additionally, there is a significant unmet need for high-quality healthcare in emerging nations, which presents several potential for companies.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Needle-Free Injection Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Needle-Free Injection Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Needle-Free Injection Market report scope?

Key Takeaways from this Needle-Free Injection Market Report

• Evaluate Needle-Free Injection market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Needle-Free Injection market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the growth rate of Needle-Free Injection Market?

The Needle-Free Injection Market is growing at a CAGR of 17.5% over the next 5 years.

Who are the key players in Needle-Free Injection Market?

Zogenix, Inovio, Glide Pharma, Akra Dermojet, Crossject Medical Technology, Injex Pharma, Eternity Healthcare, Antares Pharma, Valeritas, Medical International Technologies, PharmaJet, National Medical Products, Activa Brand Products, Endo International, Bioject Medical Technologies, Injex Pharma, National Medical Products, European Pharma Group, Penject Corporation

What are the significant types of Needle-Free Injection Market?

Powder Injections, Liquid Injections, Depot or Projectile Injection

What are the major end-use applications of Needle-Free Injection Market?

Drug Injection, Cosmetic Surgery Use, Other

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.